Efficacy of beta-blockers in the treatment of sepsis

This meta-analysis is to systematically evaluate the efficacy and safety of beta-blockers in the treatment of sepsis. A total of 17 articles that met the inclusion criteria were included, and 10,385 cases were obtained. The meta-analysis results showed that patients with sepsis with beta-blocker usa...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Jin (Author), Tao Zhao (Author), Yueyue Wei (Author), Fang Zhao (Author)
Format: Book
Published: Bangladesh Pharmacological Society, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8b115268c9c64e77b195e00b6a1c3f3a
042 |a dc 
100 1 0 |a Peng Jin  |e author 
700 1 0 |a Tao Zhao  |e author 
700 1 0 |a Yueyue Wei  |e author 
700 1 0 |a Fang Zhao  |e author 
245 0 0 |a Efficacy of beta-blockers in the treatment of sepsis 
260 |b Bangladesh Pharmacological Society,   |c 2021-01-01T00:00:00Z. 
500 |a 10.3329/bjp.v16i1.46001 
500 |a 1991-0088 
520 |a This meta-analysis is to systematically evaluate the efficacy and safety of beta-blockers in the treatment of sepsis. A total of 17 articles that met the inclusion criteria were included, and 10,385 cases were obtained. The meta-analysis results showed that patients with sepsis with beta-blocker usage had a significantly lower 28-day mortality. The heart rate decreased over time in patients with sepsis using beta-blocker. Moreover, central venous blood oxygen saturation increased after 24, 48, 72 hours of treatment; lactic acid and cardiac troponin I decreased after 48, 72 hours of treatment; and tumor necrosis factor-α, interleukin-1β levels decreased significantly after 12, 24, 48, 72 hours of treatment (p<0.05).  In conclusion, beta-blockers reduce 28-day mortality and heart rate. 
546 |a EN 
690 |a Beta-blocker 
690 |a Meta-analysis 
690 |a Sepsis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Bangladesh Journal of Pharmacology, Vol 16, Iss 1 (2021) 
787 0 |n https://www.banglajol.info/index.php/BJP/article/view/46001 
787 0 |n https://doaj.org/toc/1991-0088 
856 4 1 |u https://doaj.org/article/8b115268c9c64e77b195e00b6a1c3f3a  |z Connect to this object online.